Tower Research Capital (TRC)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Sell
22,469
-1,886
-8% -$91.7K 0.03% 507
2025
Q1
$829K Buy
24,355
+18,902
+347% +$643K 0.02% 579
2024
Q4
$215K Buy
5,453
+4,544
+500% +$179K ﹤0.01% 1667
2024
Q3
$42.7K Sell
909
-1,774
-66% -$83.3K ﹤0.01% 2810
2024
Q2
$145K Sell
2,683
-1,749
-39% -$94.5K ﹤0.01% 2321
2024
Q1
$302K Buy
4,432
+1,016
+30% +$69.3K 0.01% 1161
2023
Q4
$214K Sell
3,416
-855
-20% -$53.5K ﹤0.01% 2053
2023
Q3
$194K Sell
4,271
-9,440
-69% -$428K 0.01% 1451
2023
Q2
$770K Sell
13,711
-4,904
-26% -$275K 0.03% 677
2023
Q1
$842K Buy
18,615
+15,219
+448% +$688K 0.03% 535
2022
Q4
$138K Sell
3,396
-23,594
-87% -$959K 0.01% 1577
2022
Q3
$1.76M Buy
26,990
+9,128
+51% +$596K 0.03% 471
2022
Q2
$1.09M Buy
17,862
+11,292
+172% +$686K 0.02% 643
2022
Q1
$413K Buy
6,570
+3,485
+113% +$219K ﹤0.01% 1263
2021
Q4
$234K Buy
3,085
+173
+6% +$13.1K ﹤0.01% 1636
2021
Q3
$326K Sell
2,912
-9,149
-76% -$1.02M 0.01% 1315
2021
Q2
$1.95M Sell
12,061
-33,509
-74% -$5.43M 0.05% 313
2021
Q1
$5.55M Buy
45,570
+42,265
+1,279% +$5.15M 0.09% 192
2020
Q4
$506K Buy
3,305
+2,717
+462% +$416K 0.02% 985
2020
Q3
$49K Buy
588
+345
+142% +$28.8K ﹤0.01% 3547
2020
Q2
$18K Buy
+243
New +$18K ﹤0.01% 3729
2020
Q1
Sell
-1,016
Closed -$62K 3161
2019
Q4
$62K Buy
1,016
+969
+2,062% +$59.1K 0.01% 1201
2019
Q3
$2K Sell
47
-241
-84% -$10.3K ﹤0.01% 3664
2019
Q2
$14K Sell
288
-860
-75% -$41.8K ﹤0.01% 2372
2019
Q1
$41K Sell
1,148
-31,354
-96% -$1.12M ﹤0.01% 1864
2018
Q4
$929K Buy
32,502
+31,027
+2,104% +$887K 0.07% 283
2018
Q3
$65K Buy
1,475
+822
+126% +$36.2K ﹤0.01% 1594
2018
Q2
$38K Sell
653
-1,879
-74% -$109K ﹤0.01% 2013
2018
Q1
$116K Buy
+2,532
New +$116K 0.01% 1170
2017
Q4
Sell
-1,387
Closed -$25K 3600
2017
Q3
$25K Buy
+1,387
New +$25K ﹤0.01% 2577
2017
Q1
Sell
-479
Closed -$10K 3171
2016
Q4
$10K Buy
+479
New +$10K ﹤0.01% 2633